Immunostimulatory RNA blocks suppression by regulatory T cells

Journal of Immunology

Volumn 184, Issue 2, 2010, Pages 939-946

  Anz, David ^a   Koelzer, Viktor H ^a   Moder, Stefan ^a   Thaler, Raffael ^a   Schwerd, Tobias ^a   Lahl, Katharina ^c   Sparwasser, Tim ^c,d   Besch, Robert ^b   Poeck, Hendrik ^c   Hornung, Veit ^e   Hartmann, Gunther ^e   Rothenfusser, Simon ^a,b   Bourquin, Carole ^a   Endres, Stefan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; INTERLEUKIN 6; OLIGONUCLEOTIDE; RETINOIC ACID; TOLL LIKE RECEPTOR 7; VIRUS RNA; DDX58 PROTEIN, MOUSE; DEAD BOX PROTEIN; IFIH1PROTEIN, MOUSE; MEMBRANE PROTEIN; RNA; TLR7 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; GENOTYPE; HOMEOSTASIS; IMMUNE RESPONSE; MELANOMA; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RETINOIC ACID INDUCIBLE GENE I; RNA VIRUS; SENDAI VIRUS; SENDAI VIRUS INFECTION; VIRUS IMMUNITY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; VIROLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; BASE SEQUENCE; DEAD-BOX RNA HELICASES; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGONUCLEOTIDES; RNA; RNA VIRUSES; RNA, VIRAL; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 7;

EID: 76249117467     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901245     Document Type: Article

References (49)

1. Bluestone, J. A., and Q. Tang. 2005. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17: 638-642.
2. Sakaguchi, S., and F. Powrie. 2007. Emerging challenges in regulatory T cell function and biology. Science 317: 627-629.
3. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
4. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4 +CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
5. Lehner, T. 2008. Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation. Immunology 123: 40-44.
6. Kabelitz, D., D. Wesch, and H. H. Oberg. 2006. Regulation of regulatory T cells: role of dendritic cells and toll-like receptors. Crit. Rev. Immunol. 26: 291-306.
7. Kubo, T., R. D. Hatton, J. Oliver, X. Liu, C. O. Elson, and C. T. Weaver. 2004. Regulatory T cell suppression and anergy are differentially regulated by proin- flammatory cytokines produced by TLR-activated dendritic cells. J. Immunol. 173: 7249-7258. (Pubitemid 39628161)
8. Peng, G., Z. Guo, Y. Kiniwa, K. S. Voo, W. Peng, T. Fu, D. Y. Wang, Y. Li H. Y.Wang, and R. F.Wang. 2005. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309: 1380-1384.
9. Sutmuller, R. P., M. H. den Brok, M. Kramer, E. J. Bennink, L. W. Toonen, B. J. Kullberg, L. A. Joosten, S. Akira, M. G. Netea, and G. J. Adema. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116: 485-494.
10. Liu, H., M. Komai-Koma, D. Xu, and F. Y. Liew. 2006. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 7048-7053.
11. Crellin, N. K., R. V. Garcia, O. Hadisfar, S. E. Allan, T. S. Steiner, and M. K. Levings. 2005. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol. 175: 8051-8059.
12. Rouse, B. T., P. P. Sarangi, and S. Suvas. 2006. Regulatory T cells in virus infections. Immunol. Rev. 212: 272-286.
13. Pichlmair, A., and C. Reis e Sousa. 2007. Innate recognition of viruses. Immunity 27: 370-383.
14. Takeuchi, O., and S. Akira. 2007. Recognition of viruses by innate immunity. Immunol. Rev. 220: 214-224.
15. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531.
16. Hornung, V., M. Guenthner-Biller, C. Bourquin, A. Ablasser, M. Schlee, S. Uematsu, A. Noronha, M. Manoharan, S. Akira, A. de Fougerolles, et al. 2005. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11: 263-270.
17. Bourquin, C., L. Schmidt, V. Hornung, C. Wurzenberger, D. Anz, N. Sandholzer, S. Schreiber, A. Voelkl, G. Hartmann, and S. Endres. 2006. Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T cell and IgG2a response. Blood 109: 2953-2960.
18. Kato, H., S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira. 2005. Cell typespecific involvement of RIG-I in antiviral response. Immunity 23: 19-28.
19. Stetson, D. B., and R. Medzhitov. 2006. Antiviral defense: interferons and beyond. J. Exp. Med. 203: 1837-1841.
20. Loo, Y. M., J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez-Sobrido, S. Akira, M. A. Gill, A. García-Sastre, M. G. Katze, and M. Gale Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345.
21. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
22. Gitlin, L., W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R. A. Flavell, M. S. Diamond, and M. Colonna. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103: 8459-8464.
23. Hornung, V., J. Ellegast, S. Kim, K. Brzózka, A. Jung, H. Kato, H. Poeck, S. Akira, K. K. Conzelmann, M. Schlee, et al. 2006. 5′- Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
24. Lahl,K., C. Loddenkemper, C. Drouin, J. Freyer, J.Arnason, G. Eberl,A.Hamann, H. Wagner, J. Huehn, and T. Sparwasser. 2007. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204: 57-63.
25. Poeck, H., R. Besch, C. Maihoefer, M. Renn, D. Tormo, S. S. Morskaya, S. Kirschnek, E. Gaffal, J. Landsberg, J. Hellmuth, et al. 2008. 5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat. Med. 14: 1256-1263.
26. Diebold, S. S., C. Massacrier, S. Akira, C. Paturel, Y. Morel, and C. Reis e Sousa. 2006. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur. J. Immunol. 36: 3256-3267.
27. Valle, M., and K. Cantell. 1965. The ability of Sendai virus to overcome cellular resistance to vesicular stomatitis virus. I. General characteristics of the system. Ann. Med. Exp. Biol. Fenn. 43: 57-60.
28. Overhoff, M., and G. Sczakiel. 2005. Phosphorothioate-stimulated uptake of short interfering RNA by human cells. EMBO Rep. 6: 1176-1181.
29. Pichlmair, A., O. Schulz, C. P. Tan, T. I. Näslund, P. Liljeström, F. Weber, and C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 59-phosphates. Science 314: 997-1001.
30. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
31. Butchi, N. B., S. Pourciau, M. Du, T. W. Morgan, and K. E. Peterson. 2008. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists. J. Immunol. 180: 7604-7612.
32. Almofti, M. R., H. Harashima, Y. Shinohara, A. Almofti, Y. Baba, and H. Kiwada. 2003. Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. Arch. Biochem. Biophys. 410: 246-253.
33. Remaut, K., B. Lucas, K. Braeckmans, N. N. Sanders, J. Demeester, and S. C. De Smedt. 2006. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick? Biochemistry 45: 1755-1764.
34. Gitlin, L., S. Karelsky, and R. Andino. 2002. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418: 430-434.
35. Ovcharenko, D., R. Jarvis, S. Hunicke-Smith, K. Kelnar, and D. Brown. 2005. High-throughput RNAi screening in vitro: from cell lines to primary cells. RNA 11: 985-993.
36. Wu, A. G., X. Liu, A. Mazumder, J. A. Bellanti, and K. R. Meehan. 1999. Improvement of gene transduction efficiency in T lymphocytes using retroviral vectors. Hum. Gene Ther. 10: 977-982.
37. Rothenfusser, S., N. Goutagny, G. DiPerna, M. Gong, B. G. Monks, A. Schoenemeyer, M. Yamamoto, S. Akira, and K. A. Fitzgerald. 2005. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175: 5260-5268. (Pubitemid 41456411)
38. Libermann, T. A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-κ B transcription factor. Mol. Cell. Biol. 10: 2327-2334.
39. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
40. Moore, C. B., and J. P. Ting. 2008. Regulation of mitochondrial antiviral signaling pathways. Immunity 28: 735-739.
41. Eisenächer, K., C. Steinberg, W. Reindl, and A. Krug. 2007. The role of viral nucleic acid recognition in dendritic cells for innate and adaptive antiviral immunity. Immunobiology 212: 701-714.
42. Kornbluth, R. S., and G. W. Stone. 2006. Immunostimulatory combinations: designing the next generation of vaccine adjuvants. J. Leukoc. Biol. 80: 1084-1102.
43. Hamm, S., A. Heit, M. Koffler, K. M. Huster, S. Akira, D. H. Busch, H. Wagner, and S. Bauer. 2007. Immunostimulatory RNA is a potent inducer of antigenspecific cytotoxic and humoral immune response in vivo. Int. Immunol. 19: 297-304.
44. Meier, A., G. Alter, N. Frahm, H. Sidhu, B. Li, A. Bagchi, N. Teigen, H. Streeck, H. J. Stellbrink, J. Hellman, et al. 2007. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J. Virol. 81: 8180-8191.
45. Dannull, J., Z. Su, D. Rizzieri, B. K. Yang, D. Coleman, D. Yancey, A. Zhang, P. Dahm, N. Chao, E. Gilboa, and J. Vieweg. 2005. Enhancement of vaccinemediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115: 3623-3633.
46. Morse, M. A., A. C. Hobeika, T. Osada, D. Serra, D. Niedzwiecki, H. K. Lyerly, and T. M. Clay. 2008. Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. Blood 112: 610-618.
47. van Maren, W. W., J. F. Jacobs, I. J. de Vries, S. Nierkens, and G. J. Adema. 2008. Toll-like receptor signalling on Tregs: to suppress or not to suppress? Immunology 124: 445-452.
48. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411.
49. Kurooka, M., and Y. Kaneda. 2007. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res. 67: 227-236.